Nutte Tarn Teraphongphom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nutte Tarn Teraphongphom has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Allen Jeremias
Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA
2 shared publications Richard A. Shlofmitz
Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York
2 shared publications- Ziad A. Ali
St. Francis Hospital and Heart Center
2 shared publications Ajay Gopinath
Abbott Vascular, Santa Clara, California
1 shared publication- Ajay Gopinath
Abbott Vascular, Santa Clara, CA (J.R., A.G., N.T.T., J.B.).
1 shared publication - Akiko Maehara
The Cardiovascular Research Foundation, Columbia University, New York, USA
1 shared publication
Latest Publications
- Open Access
- 7 October 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (11) , 104001
Combining Optical Coherence Tomography and Fractional Flow Reserve for Decision Making in Percutaneous Coronary Intervention: Insights From the FUSION Study
- 7 October 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (11) , 104001
Open AccessCombining Optical Coherence Tomography and Fractional Flow Reserve for Decision Making in Percutaneous Coronary Intervention: Insights From the FUSION Study
- Open Access
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (4) , e013702
Optical Coherence Tomography–Based Functional Stenosis Assessment: FUSION—A Prospective Multicenter Trial
BACKGROUND: Intravascular imaging and intracoronary physiology may both be used to guide and optimize percutaneous coronary intervention; however, they are rarely used together. The virtual flow reserve (VFR) is an optical coherence tomography (OCT)–based model of fractional flow reserve (FFR) facilitating the assessment of the physiological significance of coronary lesions. We aimed to validate the VFR assessment of intermediate coronary artery stenoses. METHODS: FUSION (Validation of OCT-Based Functional Diagnosis of Coronary Stenosis) was a multicenter, prospective, observational study comparing OCT-derived VFR to invasive FFR. VFR was mathematically derived from a lumped parameter flow model based on 3-dimensional lumen morphology. Patients undergoing coronary angiography with intermediate angiographic stenosis (40%–90%) requiring physiological assessment were enrolled. Investigational sites were blinded to the VFR analysis, and all OCT and FFR data were reviewed by an independent core laboratory. The coprimary end points were the sensitivity and specificity of VFR against FFR as the reference standard, each of which was tested against prespecified performance goals. RESULTS: After core laboratory review, 266 vessels in 224 patients from 25 US centers were included in the analysis. The mean angiographic diameter stenosis was 65.5%±14.9%, and the mean FFR was 0.83±0.11. Overall accuracy, sensitivity, and specificity of VFR versus FFR using a binary cutoff point of 0.80 were 82.0%, 80.4%, and 82.9%, respectively. The 97.5% lower confidence bound met the prespecified performance goal for sensitivity (71.6% versus 70%; P =0.01) and specificity (76.6% versus 75%; P =0.01). The area under the curve was 0.88 (95% CI, 0.84–0.92; P <0.0001). CONCLUSIONS: OCT-derived VFR demonstrates high sensitivity and specificity for predicting invasive FFR. Integrating high-resolution intravascular imaging with imaging-derived physiology may provide synergistic benefits as an adjunct to percutaneous coronary intervention. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT04356027.
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (4) , e013702
Open AccessOptical Coherence Tomography–Based Functional Stenosis Assessment: FUSION—A Prospective Multicenter Trial
BACKGROUND: Intravascular imaging and intracoronary physiology may both be used to guide and optimize percutaneous coronary intervention; however, they are rarely used together. The virtual flow reserve (VFR) is an optical coherence tomography (OCT)–based model of fractional flow reserve (FFR) facilitating the assessment of the physiological significance of coronary lesions. We aimed to validate the VFR assessment of intermediate coronary artery stenoses. METHODS: FUSION (Validation of OCT-Based Functional Diagnosis of Coronary Stenosis) was a multicenter, prospective, observational study comparing OCT-derived VFR to invasive FFR. VFR was mathematically derived from a lumped parameter flow model based on 3-dimensional lumen morphology. Patients undergoing coronary angiography with intermediate angiographic stenosis (40%–90%) requiring physiological assessment were enrolled. Investigational sites were blinded to the VFR analysis, and all OCT and FFR data were reviewed by an independent core laboratory. The coprimary end points were the sensitivity and specificity of VFR against FFR as the reference standard, each of which was tested against prespecified performance goals. RESULTS: After core laboratory review, 266 vessels in 224 patients from 25 US centers were included in the analysis. The mean angiographic diameter stenosis was 65.5%±14.9%, and the mean FFR was 0.83±0.11. Overall accuracy, sensitivity, and specificity of VFR versus FFR using a binary cutoff point of 0.80 were 82.0%, 80.4%, and 82.9%, respectively. The 97.5% lower confidence bound met the prespecified performance goal for sensitivity (71.6% versus 70%; P =0.01) and specificity (76.6% versus 75%; P =0.01). The area under the curve was 0.88 (95% CI, 0.84–0.92; P <0.0001). CONCLUSIONS: OCT-derived VFR demonstrates high sensitivity and specificity for predicting invasive FFR. Integrating high-resolution intravascular imaging with imaging-derived physiology may provide synergistic benefits as an adjunct to percutaneous coronary intervention. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT04356027.
- Open Access
- 19 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (4)
Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial
- 19 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (4)
Open AccessEvaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial
- 14 March 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (4) , E423-E431
A global registry of fractional flow reserve (FFR)–guided management during routine care: Study design, baseline characteristics and outcomes of invasive management
Background: The use and clinical outcomes of fractional flow reserve (FFR)–guided revascularization in patients presenting with either stable coronary artery disease (CAD) or an acute coronary syndrome (ACS) in daily clinical practice are uncertain.Objective: To prospectively characterize the frequency of the change in treatment plan when FFR is performed compared to the initial decision based on angiography alone and procedure‐related outcomes.Methods: We undertook a prospective, multicenter, multinational, open‐label, observational study of coronary physiologic measurements during clinically indicated coronary angiography. The treatment plan, including medical therapy, PCI or CABG, was prospectively recorded before and after performing FFR. Adverse events were pre‐defined and prospectively recorded per local investigators (PRESSUREwire; ClinicalTrials.gov identifier: NCT02935088).Results: Two thousand two hundred and seventeen subjects were enrolled in 70 hospitals across 15 countries between October 2016–February 2018. The mean FFR (all measurements) was 0.84. The treatment plan based on angiography‐alone changed in 763/2196 subjects (34.7%) and 872/2931 lesions (29.8%) post‐FFR. In the per‐patient analysis, the initial treatment plan based on angiography versus the final treatment plan post‐FFR were medical management 1,350 (61.5%) versus 1,470 (66.9%) (p = .0017); PCI 717 (32.7%) versus 604 (27.5%) (p = .0004); CABG 119 (5.4%) versus 121 (5.5%) (p = .8951). The frequency of intended revascularization changed from 38.1 to 33.0% per patient (p = .0005) and from 35.5 to 29.6% per lesion (p < .0001) following FFR.Conclusions: On an individual patient basis, use of FFR in everyday practice changes the treatment plan compared to angiography in more than one third of all‐comers selected for physiology‐guided managements. FFR measurement is safe, providing incremental information to guide revascularization decisions.
- 14 March 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (4) , E423-E431
A global registry of fractional flow reserve (FFR)–guided management during routine care: Study design, baseline characteristics and outcomes of invasive management
Background: The use and clinical outcomes of fractional flow reserve (FFR)–guided revascularization in patients presenting with either stable coronary artery disease (CAD) or an acute coronary syndrome (ACS) in daily clinical practice are uncertain.Objective: To prospectively characterize the frequency of the change in treatment plan when FFR is performed compared to the initial decision based on angiography alone and procedure‐related outcomes.Methods: We undertook a prospective, multicenter, multinational, open‐label, observational study of coronary physiologic measurements during clinically indicated coronary angiography. The treatment plan, including medical therapy, PCI or CABG, was prospectively recorded before and after performing FFR. Adverse events were pre‐defined and prospectively recorded per local investigators (PRESSUREwire; ClinicalTrials.gov identifier: NCT02935088).Results: Two thousand two hundred and seventeen subjects were enrolled in 70 hospitals across 15 countries between October 2016–February 2018. The mean FFR (all measurements) was 0.84. The treatment plan based on angiography‐alone changed in 763/2196 subjects (34.7%) and 872/2931 lesions (29.8%) post‐FFR. In the per‐patient analysis, the initial treatment plan based on angiography versus the final treatment plan post‐FFR were medical management 1,350 (61.5%) versus 1,470 (66.9%) (p = .0017); PCI 717 (32.7%) versus 604 (27.5%) (p = .0004); CABG 119 (5.4%) versus 121 (5.5%) (p = .8951). The frequency of intended revascularization changed from 38.1 to 33.0% per patient (p = .0005) and from 35.5 to 29.6% per lesion (p < .0001) following FFR.Conclusions: On an individual patient basis, use of FFR in everyday practice changes the treatment plan compared to angiography in more than one third of all‐comers selected for physiology‐guided managements. FFR measurement is safe, providing incremental information to guide revascularization decisions.
- Top Cited PapersOpen Access
- 6 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (9) , eaaw0672
Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics
Complexation of cyanine dye with albumin produces efficient NIR-II fluorophore improving the resolution of in vivo bioimaging.
- 6 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (9) , eaaw0672
Top Cited PapersOpen AccessAlbumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics
Complexation of cyanine dye with albumin produces efficient NIR-II fluorophore improving the resolution of in vivo bioimaging.
- Open Access
- 16 October 2017
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 2 (6) , 447-452
Specimen mapping in head and neck cancer using fluorescence imaging
Overview: Although the agreed‐upon standard is circumferential pathology analysis of the interface between the resected specimen and the patient, there is currently no consensus on the optimal methodology to achieve this in head and neck cancer specimens. This is most commonly conducted by either sampling the wound bed after resection or obtaining samples from the specimen. Regardless of the technique, only a fraction of the area of interest can be sampled due to the labor‐intensive nature of frozen sections.Objective: This review will cover and define the possible role for optical mapping of the surgical specimen using fluorescence imaging in head and neck cancer.Level of Evidence: NA
- 16 October 2017
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 2 (6) , 447-452
Open AccessSpecimen mapping in head and neck cancer using fluorescence imaging
Overview: Although the agreed‐upon standard is circumferential pathology analysis of the interface between the resected specimen and the patient, there is currently no consensus on the optimal methodology to achieve this in head and neck cancer specimens. This is most commonly conducted by either sampling the wound bed after resection or obtaining samples from the specimen. Regardless of the technique, only a fraction of the area of interest can be sampled due to the labor‐intensive nature of frozen sections.Objective: This review will cover and define the possible role for optical mapping of the surgical specimen using fluorescence imaging in head and neck cancer.Level of Evidence: NA